136 related articles for article (PubMed ID: 31179360)
1. Hepatitis B virus reverse transcriptase polymorphisms between treated and treatment-naïve chronically infected patients.
Rezanezhadi M; Mohebbi A; Askari FS; Hosseini SD; Tabarraei A
Virusdisease; 2019 Jun; 30(2):219-226. PubMed ID: 31179360
[TBL] [Abstract][Full Text] [Related]
2. Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy.
Mirandola S; Sebastiani G; Rossi C; Velo E; Erne EM; Vario A; Tempesta D; Romualdi C; Campagnolo D; Alberti A
Antiviral Res; 2012 Dec; 96(3):422-9. PubMed ID: 23026293
[TBL] [Abstract][Full Text] [Related]
3. Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs.
Salpini R; Svicher V; Cento V; Gori C; Bertoli A; Scopelliti F; Micheli V; Cappiello T; Spanò A; Rizzardini G; De Sanctis GM; Sarrecchia C; Angelico M; Perno CF
Antiviral Res; 2011 Nov; 92(2):382-5. PubMed ID: 21920388
[TBL] [Abstract][Full Text] [Related]
4. The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation.
Ji D; Liu Y; Li L; Xu Z; Si LL; Dai JZ; Li X; Wang L; Yao Z; Xin SJ; Chen GF; Xu D
J Clin Virol; 2012 May; 54(1):66-72. PubMed ID: 22398037
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus reverse transcriptase mutations in treatment Naïve chronic hepatitis B patients.
Singla B; Chakraborti A; Sharma BK; Kapil S; Chawla YK; Arora SK; Das A; Dhiman RK; Duseja A
J Med Virol; 2013 Jul; 85(7):1155-62. PubMed ID: 23918533
[TBL] [Abstract][Full Text] [Related]
6. Different Variants in Reverse Transcriptase Domain Determined by Ultra-deep Sequencing in Treatment-naïve and Treated Indonesian Patients Infected with Hepatitis B Virus.
Wasityastuti W; Yano Y; Widasari DI; Yamani LN; Ratnasari N; Heriyanto DS; Okada R; Tanahashi T; Murakami Y; Azuma T; Hayashi Y
Kobe J Med Sci; 2016 Jun; 62(1):E1-8. PubMed ID: 27492206
[TBL] [Abstract][Full Text] [Related]
7. Discovery of the Novel Entecavir-Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic Analysis.
Rose RE; Hernandez D; Falk PJ; Ericson K; Zhou N; Thiry A; McPhee F
Hepatol Commun; 2018 Sep; 2(9):1123-1135. PubMed ID: 30202825
[TBL] [Abstract][Full Text] [Related]
8. Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes.
Selabe SG; Song E; Burnett RJ; Mphahlele MJ
J Med Virol; 2009 Jun; 81(6):996-1001. PubMed ID: 19382250
[TBL] [Abstract][Full Text] [Related]
9. Higher detection rates of amino acid substitutions in HBV reverse transcriptase/surface protein overlapping sequence is correlated with lower serum HBV DNA and HBsAg levels in HBeAg-positive chronic hepatitis B patients with subgenotype B2.
Su M; Xiang K; Li Y; Li Y; Deng J; Xu X; Yan L; Zhuang H; Li T
Infect Genet Evol; 2016 Jun; 40():275-281. PubMed ID: 27006281
[TBL] [Abstract][Full Text] [Related]
10. [Variability of Reverse Transcriptase Gene and S Gene in Lamivudine-treated Chronic Hepatitis B Patients].
Qian F; Qin J; Li Dongli ; Wang Weihong ; Dai L
Bing Du Xue Bao; 2015 Jul; 31(4):433-9. PubMed ID: 26524917
[TBL] [Abstract][Full Text] [Related]
11. Tenofovir is a more suitable treatment than entecavir for chronic hepatitis B patients carrying naturally occurring rtM204I mutations.
Choe WH; Kim K; Lee SY; Choi YM; Kwon SY; Kim JH; Kim BJ
World J Gastroenterol; 2019 Sep; 25(33):4985-4998. PubMed ID: 31543688
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine-resistant HBV strain rtM204V/I in acute hepatitis B.
Coppola N; Tonziello G; Colombatto P; Pisaturo M; Messina V; Moriconi F; Alessio L; Sagnelli C; Cavallone D; Brunetto M; Sagnelli E
J Infect; 2013 Oct; 67(4):322-8. PubMed ID: 23796869
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of therapy in patients with chronic hepatitis B virus.
Arrese E; Basaras M; Blanco S; Ruiz P; Cisterna R
Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):736-40. PubMed ID: 19550344
[TBL] [Abstract][Full Text] [Related]
14. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
[TBL] [Abstract][Full Text] [Related]
15. YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine.
Bozdayi AM; Uzunalimoğlu O; Türkyilmaz AR; Aslan N; Sezgin O; Sahin T; Bozdayi G; Cinar K; Pai SB; Pai R; Bozkaya H; Karayalçin S; Yurdaydin C; Schinazi RF
J Viral Hepat; 2003 Jul; 10(4):256-65. PubMed ID: 12823591
[TBL] [Abstract][Full Text] [Related]
16. The YMDD and rtA194T mutations result in decreased replication capacity in wild-type HBV as well as in HBV with precore and basal core promoter mutations.
Zhu Y; Curtis M; Borroto-Esoda K
Antivir Chem Chemother; 2011 Aug; 22(1):13-22. PubMed ID: 21860069
[TBL] [Abstract][Full Text] [Related]
17. [HBV pol/S gene mutations in chronic hepatitis B patients receiving nucleoside/nucleotide analogues treatment].
Kırdar S; Yaşa MH; Sayan M; Aydın N
Mikrobiyol Bul; 2019 Apr; 53(2):144-155. PubMed ID: 31130119
[TBL] [Abstract][Full Text] [Related]
18. [Identification the relationship between mutation patterns of rtM204I/V in the polymerase gene and genotypes of hepatitis B virus].
Yan L; Xiao L; Wei JF; Sun J; Wang ZH; Hou JL
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):423-6. PubMed ID: 22053371
[TBL] [Abstract][Full Text] [Related]
19. Investigation into drug-resistant mutations of HBV from 845 nucleoside/nucleotide analogue-naive Chinese patients with chronic HBV infection.
Li X; Liu Y; Zhao P; Wang Y; Chen L; Xin S; Zhang XX; Xu D
Antivir Ther; 2015; 20(2):141-7. PubMed ID: 24992206
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-naïve Korean patients infected with genotype C2.
Kim JE; Lee SY; Kim H; Kim KJ; Choe WH; Kim BJ
World J Gastroenterol; 2017 Jun; 23(23):4222-4232. PubMed ID: 28694662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
